ADXN
UBS Group’s Addex Therapeutics ADXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-74
| Closed | -$28 | – | 8018 |
|
|
2023
Q3 | $28 | Buy |
+74
| New | +$28 | ﹤0.01% | 7938 |
|
|
2023
Q1 | – | Sell |
-14,526
| Closed | -$9.15K | – | 8431 |
|
|
2022
Q4 | $9.15K | Buy |
14,526
+7,493
| +107% | +$4.72K | ﹤0.01% | 7492 |
|
|
2022
Q3 | $6K | Sell |
7,033
-921
| -12% | -$786 | ﹤0.01% | 7887 |
|
|
2022
Q2 | $9K | Buy |
7,954
+5,148
| +183% | +$5.83K | ﹤0.01% | 7071 |
|
|
2022
Q1 | $14K | Sell |
2,806
-14,494
| -84% | -$72.3K | ﹤0.01% | 6871 |
|
|
2021
Q4 | $109K | Buy |
17,300
+4,300
| +33% | +$27.1K | ﹤0.01% | 5170 |
|
|
2021
Q3 | $117K | Buy |
13,000
+285
| +2% | +$2.57K | ﹤0.01% | 4652 |
|
|
2021
Q2 | $122K | Buy |
12,715
+10,195
| +405% | +$97.8K | ﹤0.01% | 4693 |
|
|
2021
Q1 | $26K | Buy |
2,520
+2,420
| +2,420% | +$25K | ﹤0.01% | 6107 |
|
|
2020
Q4 | $1K | Sell |
100
-1,044
| -91% | -$10.4K | ﹤0.01% | 7158 |
|
|
2020
Q3 | $14K | Buy |
+1,144
| New | +$14K | ﹤0.01% | 5691 |
|